Androstenediol Complements Estrogenic Bioactivity During the Menopausal Transition

Overview

Journal Menopause

Specialty Gynecology & Obstetrics

Date 2012 Mar 15

PMID 22415563

Citations 18

Authors

Bill L Lasley

Jiangang Chen

Frank Z Stanczyk

Samar R El Khoudary

Nancy A Gee

Sybil Crawford

Daniel S McConnell

Affiliations

Soon will be listed here.

Abstract

Objective: The perimenopausal increase in circulating dehydroepiandrosterone sulfate (DHEAS) levels during the menopausal transition (MT) is accompanied by other adrenal steroids that have the potential to alter estrogen/androgen balance and explain the wide interwoman range of estrogen-related symptoms experienced during the MT.

Methods: Annual serum samples from the Study of Women's Health Across the Nation, which had previously been analyzed for immunoreactive estradiol (E2), testosterone, DHEAS, and sex hormone-binding globulin, were selected based on DHEAS concentration and analyzed for immunoreactive and bioactive estrogens and androgens, including immunoreactive androstenedione, dehydroepiandrosterone, and 5-androstene-3β,17β-diol (androstenediol [Adiol]).

Results: A two-fold increase in circulating androstenedione and testosterone was found to rise in parallel with the rise in circulating DHEAS, whereas dehydroepiandrosterone and Adiol concentrations rose seven- to eight-fold. Circulating Adiol, which has both androgenic and estrogenic biological activity, was significantly associated (P < 0.02) with circulating estrogen bioactivity only when E2 concentrations were low and Adiol levels were high.

Conclusions: The wide range of circulating levels of Adiol and its contribution to total circulating estrogenicity during the MT is consistent with the observed interwoman difference in symptoms at this time. Therefore, we conclude that Adiol contributes to circulating estrogenicity when E2 production falls at menopause and may contribute significantly to the endocrine changes experienced by midlife women.

Citing Articles

Dehydroepiandrosterone and Bone Health: Mechanisms and Insights.

Mohamad N, Razali N, Shamsuddin N Biomedicines. 2025; 12(12.

PMID: 39767687 PMC: 11673555. DOI: 10.3390/biomedicines12122780.

Changes in excessive alcohol use among older women across the menopausal transition: a longitudinal analysis of the Study of Women's Health Across the Nation.

Peltier M, Verplaetse T, Roberts W, Moore K, Burke C, Marotta P Biol Sex Differ. 2020; 11(1):37.

PMID: 32665024 PMC: 7362573. DOI: 10.1186/s13293-020-00314-7.

Smoking Across the Menopausal Transition in a 10-Year Longitudinal Sample: The Role of Sex Hormones and Depressive Symptoms.

Peltier M, Flores J, Smith P, Roberts W, Verplaetse T, Moore K Nicotine Tob Res. 2019; 22(6):872-877.

PMID: 31058288 PMC: 7249927. DOI: 10.1093/ntr/ntz069.

Vasomotor Symptoms Across the Menopause Transition: Differences Among Women.

Avis N, Crawford S, Green R Obstet Gynecol Clin North Am. 2018; 45(4):629-640.

PMID: 30401547 PMC: 6226273. DOI: 10.1016/j.ogc.2018.07.005.

Polymorphisms in Estrogen Synthesis Genes and Symptom Clusters During the Menopausal Transition and Early Postmenopause: Observations From the Seattle Midlife Women's Health Study.

Woods N, Cray L, Mitchell E, Farrin F, Herting J Biol Res Nurs. 2018; 20(2):153-160.

PMID: 29334760 PMC: 5942527. DOI: 10.1177/1099800417753536.

References

Poortman J . Proceedings: Interpretation of data on production and secretion rate measurements of DHEA and DHEAS. Horm Res. 1975; 6(5-6):290-1. View

Chen J, Thirkill T, Lohstroh P, Bielmeier S, Narotsky M, Best D . Bromodichloromethane inhibits human placental trophoblast differentiation. Toxicol Sci. 2003; 78(1):166-74. DOI: 10.1093/toxsci/kfh046. View

Crawford S, Santoro N, Laughlin G, Sowers M, McConnell D, Sutton-Tyrrell K . Circulating dehydroepiandrosterone sulfate concentrations during the menopausal transition. J Clin Endocrinol Metab. 2009; 94(8):2945-51. PMC: 2730879. DOI: 10.1210/jc.2009-0386. View

Dorgan J, Stanczyk F, Longcope C, STEPHENSON Jr H, Chang L, Miller R . Relationship of serum dehydroepiandrosterone (DHEA), DHEA sulfate, and 5-androstene-3 beta, 17 beta-diol to risk of breast cancer in postmenopausal women. Cancer Epidemiol Biomarkers Prev. 1997; 6(3):177-81. View

Sodergard R, Backstrom T, Shanbhag V, Carstensen H . Calculation of free and bound fractions of testosterone and estradiol-17 beta to human plasma proteins at body temperature. J Steroid Biochem. 1982; 16(6):801-10. DOI: 10.1016/0022-4731(82)90038-3. View

Davis S, Shah S, McKenzie D, Kulkarni J, Davison S, Bell R . Dehydroepiandrosterone sulfate levels are associated with more favorable cognitive function in women. J Clin Endocrinol Metab. 2007; 93(3):801-8. DOI: 10.1210/jc.2007-2128. View

England B, Parsons G, Possley R, McConnell D, Midgley A . Ultrasensitive semiautomated chemiluminescent immunoassay for estradiol. Clin Chem. 2002; 48(9):1584-6. View

Plaza F, Gabler F, Romero C, Vantman D, Valladares L, Vega M . The conversion of dehydroepiandrosterone into androst-5-ene-3beta,17beta-diol (androstenediol) is increased in endometria from untreated women with polycystic ovarian syndrome. Steroids. 2010; 75(12):810-7. DOI: 10.1016/j.steroids.2010.06.011. View

Labrie F, Martel C, Balser J . Wide distribution of the serum dehydroepiandrosterone and sex steroid levels in postmenopausal women: role of the ovary?. Menopause. 2010; 18(1):30-43. DOI: 10.1097/gme.0b013e3181e195a6. View

10.

Lasley B, Santoro N, Randolf J, Gold E, Crawford S, Weiss G . The relationship of circulating dehydroepiandrosterone, testosterone, and estradiol to stages of the menopausal transition and ethnicity. J Clin Endocrinol Metab. 2002; 87(8):3760-7. DOI: 10.1210/jcem.87.8.8741. View

11.

Janssen I, Powell L, Crawford S, Lasley B, Sutton-Tyrrell K . Menopause and the metabolic syndrome: the Study of Women's Health Across the Nation. Arch Intern Med. 2008; 168(14):1568-75. PMC: 2894539. DOI: 10.1001/archinte.168.14.1568. View

12.

JAMES K, Premchand N, Skibinska A, Skibinski G, Nicol M, Mason J . IL-6, DHEA and the ageing process. Mech Ageing Dev. 1997; 93(1-3):15-24. DOI: 10.1016/s0047-6374(96)01807-6. View

13.

Goebelsmann U, Horton R, Mestman J, Arce J, Nagata Y, Nakamura R . Male pseudohermaphroditism due to testicular 17 -hydroxysteroid dehydrogenase deficiency. J Clin Endocrinol Metab. 1973; 36(5):867-79. DOI: 10.1210/jcem-36-5-867. View

14.

Adams J . Adrenal androgens and human breast cancer: a new appraisal. Breast Cancer Res Treat. 1999; 51(2):183-8. DOI: 10.1023/a:1006050720900. View

15.

Randolph Jr J, Sowers M, Gold E, Mohr B, Luborsky J, Santoro N . Reproductive hormones in the early menopausal transition: relationship to ethnicity, body size, and menopausal status. J Clin Endocrinol Metab. 2003; 88(4):1516-22. DOI: 10.1210/jc.2002-020777. View

16.

Davis S, Panjari M, Stanczyk F . Clinical review: DHEA replacement for postmenopausal women. J Clin Endocrinol Metab. 2011; 96(6):1642-53. DOI: 10.1210/jc.2010-2888. View

17.

Lasley B, Crawford S, Laughlin G, Santoro N, McConnell D, Crandall C . Circulating dehydroepiandrosterone sulfate levels in women who underwent bilateral salpingo-oophorectomy during the menopausal transition. Menopause. 2010; 18(5):494-8. PMC: 3123411. DOI: 10.1097/gme.0b013e3181fb53fc. View

18.

Adams J, Martyn P, Lee F, Phillips N, Smith D . Metabolism of 17 beta-estradiol and the adrenal-derived estrogen 5-androstene-3 beta,17 beta-diol (hermaphrodiol) in human mammary cell lines. Ann N Y Acad Sci. 1990; 595:93-105. DOI: 10.1111/j.1749-6632.1990.tb34285.x. View